Literature DB >> 30922129

Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients.

Alba Ruiz-Gaitán1,2, Héctor Martínez3, Ana María Moret4, Eva Calabuig5, María Tasias5, Ana Alastruey-Izquierdo6, Óscar Zaragoza6, Joan Mollar3, Juan Frasquet2, Miguel Salavert-Lletí5, Paula Ramírez7, José Luis López-Hontangas2, Javier Pemán1,2.   

Abstract

BACKGROUND: Candida auris is an emerging, multidrug-resistant yeast causing hospital outbreaks. This study describes the first 24 months of the ongoing C. auris outbreak in our hospital and analyzes predisposing factors to C. auris candidemia/colonization. RESEARCH DESIGN AND METHODS: A 12-month prospective, case-controlled study was performed including a total of 228 patients (114 colonized/candidemia and 114 controls). Data from the first 79 candidemia episodes and 738 environmental samples were also analyzed. Definitive C. auris identification was performed by ITS sequencing. Antifungal susceptibility was carried out by EUCAST methodology.
RESULTS: Polytrauma (32%), cardiovascular disease (25%), and cancer (17%) were the most common underlying condition in colonized/candidemia patients. Indwelling CVC (odds ratio {OR}, 13.48), parenteral nutrition (OR, 3.49), and mechanical ventilation (OR, 2.43) remained significant predictors of C. auris colonization/candidemia. C. auris was most often isolated on sphygmomanometer cuffs (25%) patient tables (10.2%), keyboards (10.2%), and infusion pumps (8.2%). All isolates were fully resistant to fluconazole (MICs >64 mg/L) and had significantly reduced susceptibility to voriconazole (GM, 1.8 mg/L).
CONCLUSIONS: Predictor conditions to C. auris colonization/candidemia are similar to other Candida species. C. auris colonizes multiple patient's environment surfaces. All isolates are resistant to fluconazole and had significant reduced susceptibility to voriconazole.

Entities:  

Keywords:  antifungal susceptibility; candidemia; fungal colonization; outbreak

Mesh:

Substances:

Year:  2019        PMID: 30922129     DOI: 10.1080/14787210.2019.1592675

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  16 in total

1.  Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl.

Authors:  Amy R Biermann; Deborah A Hogan
Journal:  mSphere       Date:  2022-04-27       Impact factor: 5.029

2.  Evaluating the measures taken to contain a Candida auris outbreak in a tertiary care hospital in South India: an outbreak investigational study.

Authors:  Dipu Thareparambil Sathyapalan; Remya Antony; Vrinda Nampoothiri; Anil Kumar; Nandita Shashindran; Jini James; Jisha Thomas; Preetha Prasanna; Akkulath Sangita Sudhir; Jeslyn Mary Philip; Fabia Edathadathil; Binny Prabhu; Sanjeev Singh; Merlin Moni
Journal:  BMC Infect Dis       Date:  2021-05-06       Impact factor: 3.090

3.  Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018.

Authors:  Hector Felipe Garcia-Jeldes; Robyn Mitchell; Allison McGeer; Wallis Rudnick; Kanchana Amaratunga; Snigdha Vallabhaneni; Shawn R Lockhart; Amrita Bharat
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-10       Impact factor: 4.887

Review 4.  Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris.

Authors:  Farid Chaabane; Artan Graf; Léonard Jequier; Alix T Coste
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

Review 5.  Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens.

Authors:  Katharina Rosam; Brian C Monk; Michaela Lackner
Journal:  J Fungi (Basel)       Date:  2020-12-22

6.  Molecular Epidemiology of Candida Auris Outbreak in a Major Secondary-Care Hospital in Kuwait.

Authors:  Wadha Alfouzan; Suhail Ahmad; Rita Dhar; Mohammad Asadzadeh; Noura Almerdasi; Naglaa M Abdo; Leena Joseph; Theun de Groot; Walid Q Alali; Ziauddin Khan; Jacques F Meis; Mohammad R Al-Rashidi
Journal:  J Fungi (Basel)       Date:  2020-11-21

7.  Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes.

Authors:  Violeta Lara-Aguilar; Cristina Rueda; Irene García-Barbazán; Sarai Varona; Sara Monzón; Pilar Jiménez; Isabel Cuesta; Ángel Zaballos; Óscar Zaragoza
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 8.  Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?

Authors:  Raquel Sabino; Cristina Veríssimo; Álvaro Ayres Pereira; Francisco Antunes
Journal:  Microorganisms       Date:  2020-01-28

9.  Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris.

Authors:  Jingjing Chen; Sufei Tian; Xiaoxu Han; Yunzhuo Chu; Qihui Wang; Baosen Zhou; Hong Shang
Journal:  BMC Infect Dis       Date:  2020-11-11       Impact factor: 3.090

Review 10.  Candida auris: Epidemiology, biology, antifungal resistance, and virulence.

Authors:  Han Du; Jian Bing; Tianren Hu; Craig L Ennis; Clarissa J Nobile; Guanghua Huang
Journal:  PLoS Pathog       Date:  2020-10-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.